These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 7998769

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
    Latov N, Deng C, Dalakas MC, Bril V, Donofrio P, Hanna K, Hartung HP, Hughes RA, Merkies IS, van Doorn PA, IGIV-C CIDP Efficacy (ICE) Study Group.
    Arch Neurol; 2010 Jul; 67(7):802-7. PubMed ID: 20457948
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term treatment of chronic relapsing inflammatory demyelinating polyradiculoneuropathy: combination of corticosteroids, plasma exchange, and intravenous immunoglobulins.
    Briellmann RS, Nydegger UE, Sturzenegger M, Fierz L, Hess CW, Hauser SP.
    Eur Neurol; 1998 Jul; 39(3):190-1. PubMed ID: 9605400
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin.
    Choudhary PP, Hughes RA.
    QJM; 1995 Jul; 88(7):493-502. PubMed ID: 7633875
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Chronic inflammatory demyelinating polyradiculoneuropathy].
    Jakobsen JK, Lauritzen MJ, Krarup C.
    Ugeskr Laeger; 1991 Sep 02; 153(36):2474-7. PubMed ID: 1926597
    [Abstract] [Full Text] [Related]

  • 14. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies.
    van der Meché FG, van Doorn PA.
    Ann Neurol; 1995 May 02; 37 Suppl 1():S14-31. PubMed ID: 8968214
    [Abstract] [Full Text] [Related]

  • 15. Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: the ICE Study.
    Merkies IS, Bril V, Dalakas MC, Deng C, Donofrio P, Hanna K, Hartung HP, Hughes RA, Latov N, van Doorn PA, ICE Study Group.
    Neurology; 2009 Apr 14; 72(15):1337-44. PubMed ID: 19365055
    [Abstract] [Full Text] [Related]

  • 16. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
    Busby M, Donaghy M.
    J Neurol; 2003 Jun 14; 250(6):714-24. PubMed ID: 12796835
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J.
    Acta Neurol Scand; 2005 Aug 14; 112(2):115-25. PubMed ID: 16008538
    [Abstract] [Full Text] [Related]

  • 20. A critical review of therapies in acute and chronic inflammatory demyelinating polyneuropathies.
    Pollard JD.
    Muscle Nerve; 1987 Aug 14; 10(3):214-21. PubMed ID: 3031499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.